Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TQA3810 + entecavir
- Development stage
- Unknown
- Lead developer
- Chia Tai-Tianqing Pharmaceutical Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
TQA3810 + entecavir is an experimental combination therapy being studied primarily for the treatment of chronic hepatitis B. TQA3810 is a novel compound (current details on chemical class, mechanism, and full regulatory status not published), while entecavir is a well-established oral nucleoside analogue that inhibits hepatitis B virus (HBV) DNA polymerase, thereby suppressing viral replication. The combination aims to improve efficacy and potentially overcome HBV drug resistance profiles. Clinical trials have investigated their joint pharmacokinetics, safety, and efficacy; available data shows that TQA3810 is safe and well tolerated when used together with entecavir[1][5][6][7].
- Other names
- TQA3810 + entecavir
02
Targets
HBV Pol (Hepatitis B virus polymerase)TLR8 (Toll-like receptor 8)
Beyond the preview
Go deeper on TQA3810 + entecavir.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TQA3810 + entecavir.